Healthcare -
Biotechnology - NASDAQ - US
$ 2.405
-2.63 %
$ 366 M
Market Cap
-26.72
P/E
HRTX - GROSS PROFIT
Gross Profit HRTX - Heron Therapeutics, Inc.
61.9 M
LAST VALUE
23.94%
2 YEAR CAGR
4.39%
5 YEAR CAGR
14.88%
10 YEAR CAGR